Biosurfit
About:
Biosurfit develops breakthrough technologies that enable fast, precise and affordable blood analysis at the point of care.
Website: http://www.biosurfit.com
Twitter/X: Biosurfit
Top Investors: Boule Diagnostics, Portugal Ventures, Caixa Capital, PME Investimentos
Description:
At biosurfit they are working to shape the future of in-vitro diagnostic testing. They want health providers to have all the necessary information to make the best possible diagnostic and treatment decision when they are with their patients
Total Funding Amount:
10M EUR
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
Lisbon, Lisboa, Portugal
Founded Date:
2006-01-01
Contact Email:
info(AT)biosurfit.com
Founders:
Daniel Neves
Number of Employees:
51-100
Last Funding Date:
2018-12-14
IPO Status:
Private
Industries:
© 2025 bioDAO.ai